Dot1l+/− mice as well as intervention with the DOT1L small-molecular inhibitor EP5676 blunted the pulmonary fibrosis phenotypes including the collagen deposition and increased pulmonary fibrosis marker expression levels. Here, DOT1L is linked to pulmonary fibrosis.